10-Q: Research Solutions Q1 Revenue Climbs 2.2%, Net Income Up 12%
Quarterly Report
Research Solutions, Inc. reported a 2.2% increase in total revenue and a 12.0% rise in net income for the quarter ended September 30, 2025, driven by strong platform growth.
Summary
- Total revenue increased by 2.2% to $12,312,185 for the three months ended September 30, 2025, compared to $12,044,482 in the prior year.
- Platform revenue grew significantly by 18.3% to $5,120,840, attributed to additional deployments to new and existing customers, including cross-selling of the Scite product.
- Transaction revenue decreased by 6.8% to $7,191,345, primarily due to lower copyright revenues and service fees.
- Gross profit increased by 8.0% to $6,225,298, with the gross profit margin improving to 50.6% from 47.9% in the prior year.
- Net income rose by 12.0% to $749,387 for the quarter, up from $669,004 in the same period last year.
- Adjusted EBITDA increased by 15.8% to $1,472,963.
- Cash and cash equivalents decreased by $271,549 to $11,955,763 as of September 30, 2025, primarily due to cash used in financing activities.
- The first Scite earnout payment of $2,031,623 was made in August 2025, comprising $1,304,909 in cash and 264,924 shares of common stock with a fair value of $726,714.
- The contingent earnout liability related to the Scite acquisition was revalued to $12,332,983 as of September 30, 2025, down from $14,046,640 at June 30, 2025.
Sentiment
Score: 7
Explanation: The company demonstrated solid growth in platform revenue, gross profit, net income, and Adjusted EBITDA, indicating strong operational performance. The strategic focus on AI and new platform solutions is positive for future growth. However, the decline in transaction revenue and the decrease in cash due to acquisition-related payments warrant monitoring.
Positives
- Total revenue increased by 2.2% year-over-year to $12.31 million.
- Platform revenue demonstrated strong growth, increasing by 18.3% to $5.12 million, driven by new customer deployments, expansion, and cross-selling of the Scite product.
- Gross profit increased by 8.0% to $6.23 million, and the gross profit margin improved to 50.6% from 47.9%.
- Net income increased by 12.0% to $749,387.
- Adjusted EBITDA grew by 15.8% to $1.47 million, indicating improved operational efficiency.
- Income from operations increased significantly by 48.7% to $961,671.
- General and administrative expenses decreased by 13.2% to $1.68 million, primarily due to lower personnel, consulting, legal, recruiting, bad debt, and travel expenses.
- Stock-based compensation expense decreased by 49.2% to $212,482.
- The company maintains a $500,000 secured revolving line of credit with PNC Bank, with no outstanding borrowings as of September 30, 2025, indicating strong liquidity access.
Negatives
- Transaction revenue decreased by 6.8% to $7.19 million, primarily due to lower copyright revenues and service fees.
- Cash and cash equivalents decreased by $271,549 to $11,955,763, primarily due to cash used in financing activities, including significant earnout payments.
- Sales and marketing expenses increased by 40.0% to $1.67 million, driven by greater personnel costs, consulting expenses, and discretionary advertising spend.
- Foreign currency transaction gain decreased significantly by 83.4% to $17,256.
- A loss of $317,966 was recognized due to the change in fair value of the contingent earnout liability.
Risks
- No material changes from the risk factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2025 were reported.
- Operating costs could become subject to inflationary and interest rate pressures in the future, increasing costs and potentially stressing working capital resources.
- Currency exchange fluctuations may impact revenue and operating costs, particularly as costs for Reprints Desk Latin America and ResSol LA are denominated in Mexican Pesos, and the company does not currently engage in currency hedging activities.
- The preparation of financial statements involves significant estimates and assumptions (e.g., uncollectible accounts, valuation of goodwill and intangible assets, contingent earnout liabilities), and actual results could differ.
- Concentration of credit risk exists with cash and cash equivalents held in financial institutions, which at times may exceed the FDIC $250,000 insurance limit.
- The company has vendor concentrations for content costs, with Vendor A accounting for 26% and Vendor B for 10% of total content costs, posing a potential supply chain risk.
Future Outlook
The company plans to release several new Platform solutions to enhance existing research workflows and introduce new solutions to support analysis functions for its customer base. It will continually integrate and add generative AI capabilities to its Discovery Tools, Access, and Manage Platform solutions, leveraging AI models for recommendations and highly accurate results. Quarterly Scite earnout payments are scheduled to continue until the final payment in May 2027. The company is also evaluating the impact of new accounting standards ASU 2023-09 (effective fiscal year 2026) and ASU 2024-03 (effective annual periods after December 15, 2026) on its annual disclosures.
Management Comments
- We leverage our Platforms efficiencies in scalability, stability and development costs to fuel rapid innovation and competitive advantage.
- We plan to release several new Platform solutions to enhance the research workflows described above and add new solutions to support the analysis functions that exist in our typical customer base.
- Management considers our core operating performance to be that which our managers can affect in any particular period through their management of the resources that affect our underlying revenue and profit generating operations that period.
Industry Context
Research Solutions operates in the dynamic vertical software-as-a-service (SaaS) and artificial intelligence (AI) sector, specifically catering to research-intensive organizations for scientific, technical, and medical (STM) content. The company's strategic emphasis on integrating AI models, including generative AI assistants, into its platforms for enhanced search, content management, and insights aligns with the broader industry trend of AI adoption to streamline knowledge work and accelerate scientific discovery. The expansion of services to include copyright compliance for content use in AI applications and training AI models positions the company at the forefront of evolving intellectual property considerations in the AI era. The observed shift towards platform-based revenue growth, while transactional revenue declines, mirrors a common industry movement towards more stable, recurring subscription models over one-off sales in the software and information services sectors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Repurchase Policy Update | The Compensation Committee authorized an increase in the common stock repurchase cap to an aggregate value not exceeding $1,500,000 (from $750,000 plus prior balance of $330,774) and raised the repurchase price cap to $5.50 per share (from $4.00 per share). | 2024-12-19 | This change provides greater flexibility and capacity for the company to repurchase shares, particularly for satisfying employee tax obligations related to stock incentive awards, potentially reducing dilution impact from equity compensation. |
| Share Repurchase Timing Flexibility | The Compensation Committee authorized the repurchase of shares of common stock in satisfaction of tax withholding obligations at any time during a trading window, rather than only on the last day. | 2025-05-06 | This provides more operational flexibility for managing employee stock-based compensation and associated tax liabilities. |
Related Party Transactions
- Repurchases of common stock from employees to satisfy tax obligations in connection with the vesting of stock incentive awards. During the three months ended September 30, 2025, 6,390 shares were repurchased for $23,387.
Stakeholder Impact
- Shareholders: Positive impact from increased net income and Adjusted EBITDA, and improved gross profit margin. Potential dilution from common stock issued for earnout payments. Benefit from share repurchase program for tax obligations.
- Employees: Benefit from stock options and restricted stock awards, with associated compensation expense. The share repurchase program helps employees satisfy tax obligations related to vested awards.
- Customers: Benefit from enhanced SaaS platforms, advanced AI tools, and streamlined access to STM content, potentially leading to time and cost savings in research activities.
- Creditors: The company maintains a $500,000 revolving line of credit with no outstanding borrowings, indicating a stable financial position from a creditor perspective.
- Suppliers (Content Publishers): Continued arrangements with hundreds of content publishers for content distribution rights, ensuring ongoing business relationships.
Next Steps
- Release several new Platform solutions to enhance existing research workflows and support analysis functions.
- Continually add generative AI capabilities to its Discovery Tools, Access, and Manage Platform solutions.
- Continue making quarterly Scite earnout installment payments until the final payment in May 2027.
- Evaluate the impact of new accounting standards ASU 2023-09 (effective fiscal year 2026) and ASU 2024-03 (effective annual periods after December 15, 2026) on annual disclosures.
Key Dates
| Date | Description |
|---|---|
| 2006-11-02 | Research Solutions, Inc. incorporated in the State of Nevada. |
| 2007-12-01 | Established the 2007 Equity Compensation Plan. |
| 2013-03-04 | Articles of Merger Effective. |
| 2016-11-10 | Maximum number of shares for the 2007 Plan increased from 5,000,000 to 7,000,000. |
| 2017-11-21 | Stockholders approved the adoption of the 2017 Omnibus Incentive Plan, authorizing 1,874,513 shares. |
| 2019-11-01 | Became a fully remote company. |
| 2019-11-01 | Stockholders approved increases in the 2017 Omnibus Incentive Plan shares from 1,874,513 to 6,874,513 (period from November 2019 to November 2021). |
| 2022-08-19 | Long-Term Equity Bonus Program (LTEBP) became effective. |
| 2023-07-28 | Acquired ResoluteAI. |
| 2023-11-24 | Agreement of Merger and Plan of Reorganization for Scite, Inc. signed. |
| 2023-12-01 | Acquired 100% of the outstanding stock of Scite, Inc. |
| 2024-03-14 | 20% of LTEBP shares vested at a 30-day VWAP of $3.00 per share. |
| 2024-03-19 | Compensation Committee authorized common stock repurchases up to $750,000 (plus prior balance of $330,774) at prices no greater than $4.00 per share. |
| 2024-04-15 | Entered into a $500,000 secured revolving line of credit with PNC Bank, maturing April 15, 2026. |
| 2024-09-30 | End of prior fiscal quarter for comparison. |
| 2024-12-09 | 20% of LTEBP shares vested at a 30-day VWAP of $3.00 per share. |
| 2024-12-19 | Compensation Committee authorized an increase in the repurchase cap to $1,500,000 and the repurchase price cap to $5.50 per share. |
| 2025-01-03 | 20% of LTEBP shares vested at a 30-day VWAP of $3.75 per share. |
| 2025-05-06 | Compensation Committee authorized the repurchase of shares for tax withholding obligations at any time during a trading window. |
| 2025-06-30 | End of prior fiscal year. |
| 2025-07-02 | Finalized the calculation of the Scite earnout for former shareholders at $15.4 million. |
| 2025-08-01 | First of eight quarterly installment payments for Scite earnout disbursed (occurred in August 2025). |
| 2025-09-30 | End of current reporting period. |
| 2025-11-03 | Completed the second installment payment of cash and common stock associated with the Scite earnout. |
| 2025-11-07 | Number of common shares outstanding was 32,866,068. |
| 2025-11-14 | Filing date of the Form 10-Q. |
| 2027-05-01 | Scheduled final Scite earnout payment (expected by May 2027). |
Recommendation
holdWhile Research Solutions demonstrated solid growth in platform revenue, net income, and Adjusted EBITDA, the decline in transaction revenue and the cash outflow for acquisition earnouts warrant a 'hold' recommendation. The strategic focus on AI and new platform solutions is promising, but the company needs to demonstrate sustained growth across all segments and manage its cash flow effectively, especially with ongoing earnout payments. Investors should monitor the integration of Scite and the performance of new AI-driven offerings, as well as the impact of increased sales and marketing spend.
Keywords
SaaS, AI, Research Solutions, STM content, Scientific publishing, Document delivery, Scite.ai, Article Galaxy, Financial results, Quarterly report, Software, Life sciences, Academic research, Corporate research, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.